Personal Care Products

Shouxiangu

Shouxiangu released FY2026 Q1 earnings on April 29 After-Market (BJT), actual revenue CNY 161.03 M, actual EPS CNY 0.15

Shouxiangu to Release FY2026 Q1 Earnings on April 29 After-Market (BJT)

Shouxiangu released FY2025 earnings on April 22 Pre-Market (BJT), actual revenue CNY 640.18 M (forecast CNY 757 M), actual EPS CNY 0.09 (forecast CNY 0.92)

Shouxiangu released FY2025 Q4 earnings on April 22 Pre-Market (BJT), actual revenue CNY 210.04 M, actual EPS CNY -0.2637

Shouxiangu to release FY2025 earnings on April 25 Pre-Market (BJT), forecast revenue CNY 757 M, EPS CNY 0.92

Shouxiangu released FY2025 9 Months earnings on October 28 Pre-Market (BJT), actual revenue CNY 430.14 M, actual EPS CNY 0.3834

Shouxiangu released FY2025 Q3 earnings on October 28 Pre-Market (BJT), actual revenue CNY 130.45 M, actual EPS CNY 0.0567

Shouxiangu to Release FY2025 Q3 Earnings on October 29 Pre-Market BJT

Shouxiangu released FY2025 Semi-Annual Earnings on August 28 After-Market (BJT), actual revenue CNY 299.68 M, actual EPS CNY 0.33

Shouxiangu released FY2025 Q2 earnings on August 28 After-Market (BJT), actual revenue CNY 128.88 M, actual EPS CNY 0.0366

Shouxiangu to Release FY2025 Semi-Annual Earnings on August 28, 2025 (BJT)

Subsidiary of Shouxian Gu Receives Domestic Health Food Filing for Two Products

Shouxian Valley Faces Revenue Pressure, Embraces New Retail Strategy

Subsidiary of Shouxian Gu Receives Domestic Health Food Filing Certificate

Shouxian Valley Secretary Responds to Investors About Cordyceps Spore Powder Users and Future Revenue Goals

Li Zhenyu Increased Holdings in Shouxianju by 2%

Director Li Zhenyu of Shouxianguo Increases Holdings by 239,900 Shares

Shouxian Valley Plans to Enhance Cordyceps Mycelium Spore Powder Market Awareness

Shouxianju Introduces Third Generation De-Wall Ganoderma Spore Powder

Director Li Zhenyu of Shouxian Guo Increases Holdings

600572

603896

600664

On April 3rd, Tmall Health, in collaboration with dozens of well-known domestic health supplement companies such as By-Health, Caltrate, Centrum, HPGC, 21st Century, CONBA, GNC, YANGYUAN, Shouxiangu, SenShan, and Nuohui, jointly launched the "Health Supplement Assurance Alliance." The alliance aims to promote standardization, normalization, and transparency in the health supplement industry, advocating for consumers to recognize the "blue hat" label when purchasing health supplements and to choose products that better meet the nutritional and health needs of Chinese people

36Kr

CONBA

HPGC

YANGYUAN

ChinaAMC SSE STAR Biology and Medicine ETF

Guotai CSI Bio-medicine ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

Hwabao WP CSI Pharmaceuticals ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

ChinaAMC SSE Health Care ETF Initiating Fund

Founder Fubon CSI Medicine and Medical Device Innovation ETF

Ping An CSI Medicine and Medical Device Innovation ETF

E Fund Hang Seng SCHK Innovative Drug ETF

Huaan Hang Seng Biotech ETF

China Merchants CSI Biotechnology Theme ETF

ICBCCS SSE STAR Biology and Medicine ETF

Tianhong CNI BIOMEDICINE ETF

ChinaAMC CSI Biotechnology Theme ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

Bosera Hang Seng Health Care ETF(QDII)

Minsheng Royal CSI Biotechnology Theme ETF

Tmall Health has joined dozens of brands to establish the "Health Supplement Assurance Alliance"

According to the Zhitong Finance APP, Shouxiangu disclosed its third-quarter report for 2025. The company achieved revenue of 430 million yuan in the first three quarters, a year-on-year decrease of 10.23%; net profit attributable to the parent company was 76.34 million yuan, a year-on-year decrease of 33.47%; net profit excluding non-recurring gains and losses was 42.29 million yuan, a year-on-year decrease of 54.48%; basic earnings per share were 0.39 yuan

Zhitong

Shouxiangu released its performance for the first three quarters, with a net profit attributable to the parent company of 76.34 million yuan, a year-on-year decrease of 33.47%

Shouxiangu announced that its wholly-owned subsidiary Jinhua Shouxiangu Pharmaceutical Co., Ltd. has completed the re-registration of the "Shouxiangu Brand Ganoderma Spore Oil Soft Capsules" product as a domestic health food and has obtained the domestic health food registration certificate issued by the State Administration for Market Regulation. This product has been evaluated through animal experiments and is found to have health benefits that help enhance immunity, with registration number Guo Shi Jian Zhu G20200107, valid until August 25, 2030

Shouxiangu: Subsidiary "Shouxiangu Brand Ganoderma Spore Oil Soft Capsules" product completes re-registration as a domestic health food

Shouxiangu announced that the 2025 shareholder return event will be held from September 23 to October 22, 2025. Eligible shareholders can purchase the company's products at discounted prices, including Shouxiangu Xianzhi No. 3 broken-wall reishi spore powder tablets, Shouxiangu Xianzhi No. 3 broken-wall reishi spore powder, and Shouxiangu sugar-free iron skin maple granules. Individual shareholders need to participate by scanning the "Shareholder Return Event" QR code via WeChat, while corporate shareholders must submit identification information and undergo verification. The event does not constitute a profit distribution, and the company has the final interpretation rights for the event

Shouxiangu: 2025 Shareholder Return Program Launch

Shouxiangu announced that its operating revenue in the first half of 2025 was 300 million yuan, a year-on-year decrease of 16.51%. The net profit was 65.5586 million yuan, a year-on-year decrease of 33.99%

Shouxiangu: Net profit of 65.5586 million yuan in the first half of 2025, a year-on-year decrease of 33.99%

Shouxiangu announced that its wholly-owned subsidiary Jinhua Shouxiangu Pharmaceutical Co., Ltd. has completed the domestic health food filing for two products: "Shouxianyun® Broken Wall Ganoderma Spore Powder Tablets" and "Shouxianhong® Broken Wall Ganoderma Spore Powder Tablets," and has obtained the filing certificate from the Zhejiang Provincial Market Supervision Administration. This filing will help enrich the company's product line, enhance its competitiveness in the health food sector, and align with the company's strategic planning in the big health industry

Shouxiangu: Two products have completed the domestic health food filing

Shouxiangu's wholly-owned subsidiary Jinhua Shouxiangu Pharmaceutical Co., Ltd. has completed the domestic health food filing for its "Shouxianyun® Broken Wall Ganoderma Spore Powder" product and obtained the filing certificate from the Zhejiang Provincial Market Supervision Administration. This filing will help enrich the company's product line, enhance its competitiveness in the health food sector, and align with the company's strategic planning in the big health industry

Shouxiangu's subsidiary "Shouxianyun® Broken Wall Ganoderma Spore Powder" has completed the domestic health food filing

On the evening of June 3rd, Shouxiangu announced that its wholly-owned subsidiary Jinhua Shouxiangu Pharmaceutical Co., Ltd.'s product "Shouxiang Liangpin® Broken Wall Ganoderma Spore Powder" has completed the filing work for domestic health food and has obtained the domestic health food filing certificate issued by the Zhejiang Provincial Market Supervision Administration

Shouxiangu: Wholly-owned subsidiary's products complete domestic health food filing

603866

002812

In the past 10 days, there have been 54 records of executives increasing their holdings involving 28 companies, with a total increase of 24.9729 million shares and a capital amount of 178 million yuan. Toly Bread ranks first with an increase of 21.6799 million shares and an amount of 108 million yuan, while Shouxiangu and ENERGY TECHNOLOGY rank second and third with 31.66 million yuan and 22.1109 million yuan, respectively. Jinhui Co., Ltd. and Shanghai Energy each had 4 executives increase their holdings, and both Jingsheng Electronics and Jinkai New Energy also had multiple executives increase their holdings

Toly Bread

ENERGY TECHNOLOGY

NYOCOR Co., Ltd.

JINHUI INC.

SHANGHAI ENERGY

JOYSON ELECTRONICS

In the past 10 days, executives have significantly increased their holdings, with Toly Bread and others leading in the amount of increase

According to the announcement from Shouxiangu, from April 30, 2025, to May 23, 2025, one of the actual controllers, director, and general manager Li Zhenyu increased his holdings in the company by 3.9648 million shares through centralized bidding on the Shanghai Stock Exchange, accounting for 2% of the company's total share capital, with a total increase amount of 82.0992 million yuan (excluding transaction fees), and an average purchase price of 20.71 yuan/share. This increase plan has been completed

Shouxiangu's actual controller Li Zhenyu has cumulatively increased his holdings in the company by 2%

Shouxiangu(603896.SH)